US Adults’ Likelihood to Participate in Dementia Prevention Drug Trials: Results from the National Poll on Healthy Aging

por Cox, Chelsea G., Davis, M. A., Grill, J. D., Roberts, J. S.
Publicado 2022

The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD): A Novel Clinical Trials Training Program

por Berkness, Tyler, Carrillo, M. C., Sperling, R., Petersen, R., Aisen, P., Flournoy, C., Snyder, H., Raman, R., Grill, J. D.
Publicado 2021

Alzheimer’s Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer’s Clinical Trial Consortium Sites

por Rhodus, Elizabeth K., Aisen, P., Grill, J. D., Rentz, D. M., Petersen, R. C., Sperling, R. A., Salloway, S. P., Pierce, D., Raman, R.
Publicado 2022

Tackling a Major Deficiency of Diversity in Alzheimer’s Disease Therapeutic Trials: An CTAD Task Force Report

por Raman, Rema, Aisen, P., Carillo, M. C., Detke, M., Grill, J. D., Okonkwo, O. C., Rivera-Mindt, M., Sabbagh, M., Vellas, B., Weiner, M., Sperling, R.
Publicado 2022

Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD)

por Walter, S., Clanton, T.B., Langford, O.G., Rafii, M.S., Shaffer, E.J., Grill, J.D., Jimenez-Maggiora, G.A., Sperling, R.A., Cummings, J.L., Aisen, P.S.
Publicado 2020

Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data

por Amariglio, R.E., Sikkes, S.A.M., Marshall, G.A., Buckley, R.F., Gatchel, J.R., Johnson, K.A., Rentz, D.M., Donohue, M.C., Raman, R., Sun, C.-K., Yaari, R., Holdridge, K.C., Sims, J.R., Grill, J.D., Aisen, P.S., Sperling, R.A.
Publicado 2021